Evidence map›Paper›PMID 35815213›Full record

ArticleFrontiers in chemistry2022

Synthesis and Biological Evaluation of 5-Fluoro-2-Oxindole Derivatives as Potential α-Glucosidase Inhibitors.

Jing Lin, Qi-Ming Liang, Yuan-Na Ye, Di Xiao, Li Lu, Meng-Yue Li, Jian-Ping Li, Yu-Fei Zhang, Zhuang Xiong, Na Feng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jing LinSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Qi-Ming LiangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Yuan-Na YeSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Di XiaoSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Li LuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Meng-Yue LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Jian-Ping LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Yu-Fei ZhangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Zhuang XiongSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Na FengSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Chen LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Wuyi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-Glucosidase inhibitors are known to prevent the digestion of carbohydrates and reduce the impact of carbohydrates on blood glucose. To develop novel α-glucosidase inhibitors, a series of 5-fluoro-2-oxindole derivatives (

Indexed as

dockinginhibitionkineticsoxindoleα-glucosidase

Identifiers

PMID35815213
PMCPMC9261963
OpenAlexW4283316294

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.